Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Change in Cash (2016 - 2025)

Historic Change in Cash for Cryo Cell International (CCEL) over the last 16 years, with Q3 2025 value amounting to $127716.0.

  • Cryo Cell International's Change in Cash rose 14699.62% to $127716.0 in Q3 2025 from the same period last year, while for Aug 2025 it was $67770.0, marking a year-over-year increase of 11753.16%. This contributed to the annual value of $154893.0 for FY2024, which is 11193.42% up from last year.
  • Cryo Cell International's Change in Cash amounted to $127716.0 in Q3 2025, which was up 14699.62% from -$85631.0 recorded in Q2 2025.
  • Over the past 5 years, Cryo Cell International's Change in Cash peaked at $916686.0 during Q1 2021, and registered a low of -$6.1 million during Q1 2022.
  • Its 5-year average for Change in Cash is -$531364.1, with a median of -$177929.0 in 2023.
  • Its Change in Cash has fluctuated over the past 5 years, first plummeted by 8491258.28% in 2021, then surged by 30430.79% in 2024.
  • Over the past 5 years, Cryo Cell International's Change in Cash (Quarter) stood at $562282.0 in 2021, then tumbled by 317.1% to -$1.2 million in 2022, then soared by 85.42% to -$177929.0 in 2023, then surged by 304.31% to $363523.0 in 2024, then crashed by 64.87% to $127716.0 in 2025.
  • Its last three reported values are $127716.0 in Q3 2025, -$85631.0 for Q2 2025, and -$337838.0 during Q1 2025.